Drug Shortage Report for SANDOZ TAMSULOSIN CR
Report ID | 216208 |
Drug Identification Number | 02340208 |
Brand name | SANDOZ TAMSULOSIN CR |
Common or Proper name | TAMSULOSIN CR |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | TAMSULOSIN HYDROCHLORIDE |
Strength(s) | 0.4MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 500PRT |
ATC code | G04CA |
ATC description | DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-01-17 |
Estimated end date | 2024-04-12 |
Actual end date | 2024-04-08 |
Shortage status | Resolved |
Updated date | 2024-04-09 |
Company comments | |
Health Canada comments | |
Tier 3 Status | Yes |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2024-04-09 | English | Compare |
v9 | 2024-04-08 | French | Compare |
v8 | 2024-04-08 | English | Compare |
v7 | 2024-03-05 | French | Compare |
v6 | 2024-03-05 | English | Compare |
v5 | 2024-01-30 | English | Compare |
v4 | 2024-01-18 | English | Compare |
v3 | 2024-01-17 | French | Compare |
v2 | 2024-01-17 | English | Compare |
v1 | 2024-01-17 | English | Compare |
Showing 1 to 10 of 10